Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists

Author(s):  Cutter Christopher B

Issue:  Nov/Dec 2000 - Compounding for Hormone Replacement Therapy
View All Articles in Issue

Page(s):  432-437

Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists Page 1
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists Page 2
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists Page 3
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists Page 4
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists Page 5
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists Page 6

Download in electronic PDF format for $75

Abstract:  In this article, the author reviews the basic pathophysiological mechanisms of hypogonadism, emphasizing the role of the compounding pharmacist in the case of these special patients. Regarding compounding gels, he reports on a clinical study involving 10 men that he conducted in 1988 showing that compounded testosterone gels (Pluronic lecithin organogel) or an alcohol-based gel was highly effective and met with high patient acceptance. Patients were withdrawn from their previous testosterone therapy and had baseline levels of hormones measured 2-4 weeks later. Therapy was initiated with testosterone Pluronic lecithin organogel at low doses (1% to 1.5%, 1 to 2 mL) applied at bedtime. Serum levels of total and free testosterone were drawn at weekly intervals, and the amount or concentration of the testosterone gel was then increased as needed. Although some begin to exhibit therapeutic levels of testosterone at the initial dose, most required much higher concentrations (up to 10%). After doses had been titrated upward for 2 weeks, all subjects exhibited adequate therapeutic levels of total androgens. However, results demonstrated great intra- and interpatient variation in response to therapy, so monitoring serum hormone levels was essential for proper titration of the dose. An estimated absorption efficiency of the gels was from 6% to 50% of the applied amount. The author also discusses percutaneous therapy, application site and patient monitoring. He concludes that testosterone gels are effective when properly used and that monitoring the levels of androgens and estrogen enables the physician to determine the effectiveness of the prescribed dosage and application site. Compounded preparations have the advantages of providing dosing flexibility and being priced very reasonably. Tables provide information regarding causes of primary and secondary hypogonadism, disease states associated with hypogonadism, medication and factors associated with hypogonadism, symptoms and

Related Keywords: decreased libido, hypogonadism, percutaneous testosterone, sexual dysfuction, testosterone, testosterone gel, topical testosterone

Related Categories: DERMATOLOGY, HRT, FREE SAMPLES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists
Cutter Christopher B
Nov/Dec 2000
Pg. 432-437

View Sample
Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Needham Shawn
, Needham Shane
Nov/Dec 2018
Pg. 466-468

Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
May/Jun 2015
Pg. 195-203

Testosterone Deficiency in Men: New Treatments for Andropause
Biundo Bruce
, Shippen Eugene
Nov/Dec 2000
Pg. 429-431

Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Kells John
, DollbaumCharles M
Mar/Apr 2011
Pg. 102-112

In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream
Lehman Paul A
, Raney Sam G
May/Jun 2012
Pg. 248-252

Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 73

Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 151

Testosterone 1% in Alcoholic Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 72

Testosterone-Menthol Eutectic Ointment (2% Testosterone)
Allen Loyd V Jr
Mar/Apr 1999
Pg. 137

Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography
Gupta Vishnu D
Mar/Apr 1999
Pg. 158-159

Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L
, York Anne E
Jul/Aug 2019
Pg. 325-339

Hormone Treatment Options for Males: What to Do for Men with Low Testosterone
Biundo Bruce
Jul/Aug 2009
Pg. 276-279

Hormone Treatment Options for Males: What to do for Men with Low Testosterone
Biundo Bruce
Jan/Feb 2024
Pg. 28-32

Testosterone 50-mg/mL Topical Gel
Allen Loyd V Jr
Jul/Aug 2002
Pg. 302

Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate?
Tan Robert S
Nov/Dec 2004
Pg. 419-423

Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Biundo Bruce
Sep/Oct 2023
Pg. 358-360

Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Tan Robert S
Jul/Aug 2005
Pg. 259-264

View Sample
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Return to Top